Voices of Otolaryngology


The Official AAO-HNS/F Podcast App


Learn about the very latest in otolaryngology education, how to get involved with the Academy, news about upcoming events, including the Annual Meeting & OTO EXPO, and more!


The views and opinions expressed in any podcast are those of the participants and do not necessarily represent the positions, policies, or thoughts of the American Academy of Otolaryngology–Head and Neck Surgery, its leadership, or its employees.

Featured Podcast

Voices of Otolaryngology: Navigating Immunotherapy Options for Allergic Rhinitis: SCIT vs. SLIT

In this special edition of Voices of Otolaryngology, join Cecelia Damask, DO, and Matthew W. Ryan, MD, as they explore the critical differences between subcutaneous and sublingual immunotherapy for allergic rhinitis treatment. This in-depth discussion covers efficacy comparisons, safety profiles, cost considerations, and practical factors affecting patient adherence. Learn how these immunotherapy approaches can modify disease progression beyond symptom management and discover strategies for individualizing treatment plans for those suffering from allergic rhinitis.

Resources:

Clinical Practice Guideline: Immunotherapy for Inhalant Allergy

ENThealth.org Treatment Options for Allergen Immunotherapy

ENThealth.org FAQs about Allergen Immunotherapy

Wherever you are, and whatever device you are using, you can now listen to each new Voices of Otolaryngology episode as soon as it publishes. The Voices of Otolaryngology episodes are authored by thought leaders from a wide array of physicians within the specialty and offer keen insights on the latest issues affecting you and your patients.

No External Use or Transfer (Including AI-Based Technologies): The materials and content on this website are provided for personal, non-commercial transitory viewing only. You are prohibited from copying or transferring any materials or content accessed through this website into applications, software, bots, or websites which may allow third parties to retain or use the content, including but not limited to those using artificial intelligence-based technologies or infrastructure. Please see the Terms of Use for more information.